Please complete the CAPTCHA to continue
@harvard.edu
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Eitan Akirav, Ph.D. is listed as Dynamic Biotech Leader with a Dual Focus on Scientific Innovation and Business Strategy at KonKai Ventures, based in Boston, Massachusetts, United States. AeroLeads shows a work email signal at harvard.edu and a matched LinkedIn profile for Eitan Akirav, Ph.D..
Eitan Akirav, Ph.D. previously worked as Founder and CEO at Konkai Ventures and Scientific Advisory Board Member at Kihealth. Eitan Akirav, Ph.D. holds Postdoctoral Training, Autoimmunity And Diabetes from Yale School Of Medicine.
This section adds company-level context without repeating Eitan Akirav, Ph.D.'s masked contact details.
AeroLeads found 1 current-domain work email signal for Eitan Akirav, Ph.D.. Compare company email patterns before reaching out.
As a seasoned biotech leader with over 17 years of experience, I bring a unique blend of scientific innovation and business strategy to the biotechnology and healthcare sectors. My career spans top-tier academic institutions and leading biotech companies, where I’ve consistently driven growth, fostered innovation, and built cross-functional teams that deliver impactful results.At Cerba Research, I transformed the Global Biomarker Program, leading a geographically diverse team across Europe, APAC, and the USA to increase revenue. By establishing a robust pipeline, I secured the company's market position during the pandemic. At Enzo, I spearheaded the development of diagnostic platforms, enabling rapid COVID-19 testing at the pandemic's onset and providing solutions for women's health.Earlier in my career at NYU, I built and funded a groundbreaking autoimmunity research program, securing millions in funding, leading five clinical trials, and bringing innovative diagnostic assays to market. My research has been featured in prestigious journals like PNAS and Nature Immunology, showcasing my commitment to advancing science.Beyond my professional achievements, I served as a peer reviewer and advocate for organizations like JDRF and the National MS Society, where I contributed expert insights to advance research and funding initiatives. I am passionate about bridging the gap between scientific discovery and business application, creating meaningful solutions that drive both innovation and market success.Feel free to connect with me here on LinkedIn to discuss potential collaborations, partnerships, or opportunities to drive impactful innovation together.
Listed skills include Immunology, Cell, Molecular Biology, Life Sciences, and 51 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
• Spearheaded the development of innovative healthcare investment strategies, new product positioning, and strategic business development services at Konkai Ventures.• Implemented cutting-edge approaches to drive growth and enhance market positioning within the healthcare industry.• Achieved significant revenue growth and market expansion through strategic partnerships and new product development initiatives.
Saint Augustine, Fl, Us
Ki-Health is committed to advancing a holistic approach to metabolic disease through novel diagnostics, products, and services is exciting!
Cambridge, Massachusetts, Us
* Identified market needs and advised on scientific advancements to create financially sound commercialization pathways, reducing risk and enhancing market readiness.* Established high-impact partnerships and secured optimal intellectual property agreements to maximize research impact and drive technology commercialization.
Ghent, Flemish Region, Be
* Spearheaded strategic initiatives in corporate and business development, talent management, and biomarker innovation to drive revenue growth, expand market presence, and enhance diagnostic offerings through targeted partnerships and scientific expertise, including securing a multimillion clinical trial partnership in APAC and doubling sales team revenue within eight months.* Directed biomarker development from preclinical to clinical stages, ensuring rigorous therapeutic study requirements while aligning Cerba’s capabilities with evolving industry demands in immuno-oncology, cell-based therapies, and solid tumors, strengthening partnerships and delivering clinical milestones with precision.
Farmingdale, Ny, Us
* Directed the development of molecular diagnostics platforms, securing reagent supplies, managing compliance, and driving contract negotiations to position Enzo as a leading COVID-19 testing provider in NY and NJ during the pandemic. Oversaw the launch of FISH and IHC services and reagents, expanding diagnostic capabilities across U.S. and global markets while ensuring compatibility and supply chain efficiency.* Built a high-caliber business development team of Ph.D. professionals, driving scientific innovation and market expansion through strategic R&D initiatives in women’s health, STDs, and cervical cancer. Executed go-to-market strategies and ensured regulatory compliance (GMP, IVD/CE, FDA), enhancing Enzo’s adaptability and resilience amid industry challenges.
Mineola, Ny, Us
* Pioneered the first biomarker using circulating-cell-free DNA to measure cell loss in diseases such as diabetes, multiple sclerosis, and Parkinson's disease, introducing a minimally invasive diagnostic method featured in PNAS and Newsday for its groundbreaking impact on hard-to-access tissues like the brain and pancreas.* Secured substantial funding from JDRF and the National MS Society, led IRB-approved clinical trials in collaboration with NYU, and directed multidisciplinary teams to publish high-impact findings in journals such as Nature Immunology and Journal of Biological Chemistry, advancing both scientific innovation and institutional prestige.
Quick answers generated from the profile data available on this page.
Eitan Akirav, Ph.D. works for KonKai Ventures.
Eitan Akirav, Ph.D. is listed as Dynamic Biotech Leader with a Dual Focus on Scientific Innovation and Business Strategy at KonKai Ventures.
AeroLeads has found 1 work email signal at @harvard.edu for Eitan Akirav, Ph.D. at KonKai Ventures.
Eitan Akirav, Ph.D. is based in Boston, Massachusetts, United States while working with KonKai Ventures.
Eitan Akirav, Ph.D. has worked for Konkai Ventures, Kihealth, Harvard University, Cerba Research, and Stony Brook University.
You can use AeroLeads to view verified contact signals for Eitan Akirav, Ph.D. at KonKai Ventures, including work email, phone, and LinkedIn data when available.
Eitan Akirav, Ph.D. holds Postdoctoral Training, Autoimmunity And Diabetes from Yale School Of Medicine.
Eitan Akirav, Ph.D. is listed with skills including Immunology, Cell, Molecular Biology, Life Sciences, In Vivo, Cell Culture, Scientific Writing, and Cell Biology.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts